key: cord-0857830-2i2ugz9y
authors: Lotti, Marco; Giulii Capponi, Michela; Dokic, Dusanka; Bertoli, Paolo; Lucianetti, Alessandro
title: Unsuspected clinical presentation of coronavirus disease 2019: acute bowel disease
date: 2020-08-08
journal: ANZ J Surg
DOI: 10.1111/ans.16213
sha: 0567b1e51bd9b1998b528cd7c91b1ea565538b5e
doc_id: 857830
cord_uid: 2i2ugz9y

nan

The patient was readmitted for repeated episodes of rectal bleeding after 2 days.

The contrast-enhanced abdominal CT scan revealed submucosal oedema of the ascending colon, with mucosal hyperaemia, patent mesenteric vessels and mild shrinking of the retroperitoneal haematoma (Fig. 1c) . A colonoscopy was also performed (Fig. 1d) ; mucosal hyperaemia and oedema with ulcerations of the ascending colon were described.

Attributing the intestinal manifestations to COVID-19 infection, the patient was treated with oxygen therapy, hydroxychloroquine, darunavir/cobicistat, methylprednisolone and piperacillin/ tazobactam. At the time of manuscript submission, the patient was still admitted to the hospital, but had clinically improved with resolution of rectal bleeding.

COVID-19 presents with gastrointestinal (GI) symptoms (anorexia 83.8%, diarrhoea 29.3%, vomiting 0.8% and abdominal pain 0.4%) associated with respiratory symptoms in almost half of the cases. This presentation is more likely in elderly population and the GI manifestations alone are extremely rare. 1 When GI system is involved, the physical examination usually shows only moderate distension of the abdomen with mild tenderness. However, an unexpected frequency of segmental thickening with marked oedema of the bowel wall or the occurrence of segmental dilatation of the colon found after performing bowel sonography and CT scan can be suggestive for bowel ischaemia. When colonoscopy is feasible, segmental bowel ischaemia with mucosal ulcerations, Fig 1. (a, b) Retroperitoneal haematoma with active bleeding due to a ruptured aneurysm of the pancreaticoduodenal arcade (green arrows); (c) submucosal oedema of the ascending colon, with mucosal hyperaemia (yellow arrows) and patent mesenteric vessels (red arrow); (d) colonoscopy. microhaemorrhages and focal vascular congestion can be observed. Eventually, surgery can become a necessary therapeutic option.

Several hypotheses can be made to explain those findings. First, the observed abnormalities could be due to COVID-19 enterocolitis, which usually presents with nausea, vomiting, fever and watery or bloody diarrhoea. 2, 3 Second, the reduction in the number of functioning angiotensinconverting enzyme 2 receptors, due to binding to the severe acute respiratory syndrome coronavirus 2 spike protein, could decrease the synthesis of angiotensin 1-7, a peptide that exerts protective effects against bowel inflammation, restores mesenteric blood flow and reduces oxidative stress to the bowel. [4] [5] [6] Third, damage to the intestinal microvasculature and microvascular obstruction can be consequences of the COVID-19 infection, which has been recently correlated with a state of hypercoagulability 7 and with endothelial dysfunction. 8 In these conditions, a small reduction of the intestinal blood flow can be deleterious in elderly patients with pre-existing impaired bowel perfusion.

Finally, the composition of gut microbiota, which differs among patients and is altered by the use of antibiotics, could contribute to bowel inflammation and explain why the right colon is most often affected, as microbiota differs between the left and the right colon and the bacterial biofilm is preferentially formed on the latter one. 9, 10 This case demonstrates that bowel pathology from COVID-19 can be part of a multisystem involvement and COVID-19 patients should be thoroughly evaluated, even in case of mild abdominal symptoms, as the intestinal picture, although rare, may be lifethreating.

Coronavirus disease (COVID-19): a primer for emergency physicians

SARS-CoV-2 enterocolitis with persisting to excrete the virus for approximately two weeks after recovering from diarrhea: a case report

SARS-CoV-2 gastrointestinal infection causing hemorrhagic colitis: implications for detection and transmission of COVID-19 disease

Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics

Antiinflammatory action of angiotensin 1-7 in experimental colitis

An update on the tissue renin angiotensin system and its role in physiology and pathology

Hypercoagulability of COVID-19 patients in intensive care unit. A report of thromboelastography findings and other parameters of hemostasis

Systemic arterial thrombosis and acute mesenteric ischemia in a patient with COVID-19

Differences regarding the molecular features and gut microbiota between right and left colon cancer

Novel coronavirus infection and gastrointestinal tract